New Brazilian biotech patent examination guidelines a “missed opportunity”

Despite providing important clarifications, newly published patent examination guidelines in Brazil for biotech inventions pose many difficulties for life sciences innovators – but there is some good news, too

Enter your details below to log into your account.

Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Twitter

01 Aug 2021

@IAM_Alerts The Sunday Supplement is out, rounding up all the week’s big IP developments, including: Nokia’s huge licensing mar… https://t.co/vEJvBGzMqX Read more

31 Jul 2021

@IAM_Alerts Dozens of tech businesses have promised to track patenting performance among women and other under-represented inve… https://t.co/QfoyynVQpn Read more

30 Jul 2021

@IAM_Alerts The only major innovators that sit outside Via's new pool seem to be Qualcomm and Technicolor… https://t.co/CUiy0mtnK1 Read more

30 Jul 2021

@IAM_Alerts This looks to be far more significant than the news out of South Africa earlier in the week … https://t.co/BOkuv5fdEk Read more